NRx Pharmaceuticals announced the release of the first batches manufactured in the U.S. of NRX-101, its Phase 3-ready investigational drug, targeting suicidal bipolar depression and with future study plans for ...Read more

NRXP News on the Web

2022-11-25

Premarket Mover: NRX Pharmaceuticals Inc (NRXP) Down 3.67%

Investors Observer

Neutral

2022-11-22

Can NRX Pharmaceuticals Inc (NRXP) Stock Rise to the Top of Healthcare Sector Tuesday?

Investors Observer

Neutral

2022-11-21

Where Does NRX Pharmaceuticals Inc (NRXP) Stock Fall in the Biotechnology Field After It Has Risen 14.44% This Week?

Investors Observer

Neutral

2022-11-18

Where Will NRX Pharmaceuticals Inc (NRXP) Stock Go Next After It Is Up 24.00% in a Week?

Investors Observer

Neutral

2022-11-17

Healthcare Stocks Making Moves Thursday: CTMX, BDSX, TCRT, NRXP, NOTV, BVS, TNYA, IMCC

Investors Observer

Neutral

2022-11-15

Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP) and Arcutis Biotherapeutics (ARQT)

TipRanks News

Bullish

2022-11-14

NRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

Yahoo Finance

Neutral

2022-11-14

Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

NRXP

Sector Average

Media Buzz

This Week2 articles

Weekly Average2.75 articles

News Sentiment

This Week50%

Sector Average60%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

Healthcare Stocks that are Trending in the News

MRTXMirati Therapeutics

QUREuniQure

MDTMedtronic

OBSVObsEva SA

BMRNBioMarin Pharmaceutical

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing